Evidence map›Paper›PMID 33679136›Full record

ReviewJournal of inflammation research2021

The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic.

Nandeeta Samad, Temitayo Eniola Sodunke, Abdullahi Rabiu Abubakar, Iffat Jahan, Paras Sharma, Salequl Islam, Siddhartha Dutta, Mainul Haque

Open access · goldAbstract readReview
In one paragraph

Review in Journal of inflammation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2022
    Review
  15. Review
  16. Serum zinc levels in pediatric patients with COVID-19.European journal of pediatrics · 2022
    Observational
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 4 countries.

Nandeeta SamadDepartment of Public Health, North South University, Dhaka, 1229, Bangladesh.ORCID 0000-0002-3623-0743
Temitayo Eniola SodunkeDepartment of Anatomy, University of Ilorin, Ilorin, Kwara State, Nigeria.ORCID 0000-0001-8214-6705
Abdullahi Rabiu AbubakarDepartment of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, 700233, Nigeria.ORCID 0000-0002-9740-7856
Iffat JahanDepartment of Physiology, Eastern Medical College, Cumilla, Bangladesh.ORCID 0000-0003-0551-3609
Paras SharmaDepartment of Pharmacognosy, BVM College of Pharmacy, Gwalior, India.ORCID 0000-0003-0107-2666
Salequl IslamDepartment of Microbiology, Jahangirnagar University, Dhaka, 1342, Bangladesh.ORCID 0000-0001-6131-4132
Siddhartha DuttaDepartment of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.ORCID 0000-0001-6525-5950
Mainul HaqueThe Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia.ORCID 0000-0002-6124-7993
All India Institute of Medical Sciences Jodhpur · INBayero University Kano · NGEastern Medical College and Hospital · BDJahangirnagar University · BDNational Defence University of Malaysia · MYNorth South University · BDUniversity of Ilorin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global pandemic from COVID-19 infection has generated significant public health concerns, both health-wise and economically. There is no specific pharmacological antiviral therapeutic option to date available for COVID-19 management. Also, there is an urgent need to discover effective medicines, prevention, and control methods because of the harsh death toll from this novel coronavirus infection. Acute respiratory tract infections, significantly lower respiratory tract infections, and pneumonia are the primary cause of millions of deaths worldwide. The role of micronutrients, including trace elements, boosted the human immune system and was well established. Several vitamins such as vitamin A, B6, B12, C, D, E, and folate; microelement including zinc, iron, selenium, magnesium, and copper; omega-3 fatty acids as eicosapentaenoic acid and docosahexaenoic acid plays essential physiological roles in promoting the immune system. Furthermore, zinc is an indispensable microelement essential for a thorough enzymatic physiological process. It also helps regulate gene-transcription such as DNA replication, RNA transcription, cell division, and cell activation in the human biological system. Subsequently, zinc, together with natural scavenger cells and neutrophils, are also involved in developing cells responsible for regulating nonspecific immunity. The modern food habit often promotes zinc deficiency; as such, quite a few COVID-19 patients presented to hospitals were frequently diagnosed as zinc deficient. Earlier studies documented that zinc deficiency predisposes patients to a viral infection such as herpes simplex, common cold, hepatitis C, severe acute respiratory syndrome coronavirus (SARS-CoV-1), the human immunodeficiency virus (HIV) because of reducing antiviral immunity. This manuscript aimed to discuss the various roles played by zinc in the management of COVID-19 infection.

Indexed as

COVID-19efficacyimmune-boostingmicroelementpandemicpneumoniaviral infectionszinc therapy

Identifiers

PMID33679136
PMCPMC7930604
OpenAlexW3131654412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.